Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy

Fig. 3

Concentrations for serotype-specific anti-pneumococcal (a) and anti-tetanus (b) IgG antibodies. All concentrations were significantly higher compared to baseline (p ≤ 0.001). CI = confidence interval; PCV-13 = 13-serotype pneumococcal conjugate vaccine; TTV = tetanus toxoid vaccine

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us